Internal Server Error

About Breakout Labs

Breakout Labs is a venture capital firm founded in 2011. It is primarily based out of San Francisco, United States. As of Jul 2022, Breakout Labs has invested in 44 companies. It primarily invests in Seed round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and HealthTech. Most recently it participated in the $***** Seed round of NAPIGEN Overall, Breakout Labs portfolio has seen 2 IPOs and 3 acquisitions including key companies like Azitra, Quince Therapeutics and FlightWave Aerospace. A lot of funds co-invest with Breakout Labs, with names like Horizons Ventures sharing a substantial percentage of its portfolio. Breakout Labs has team of 2 people including 2 partners.
Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Grant (prize money) & 2 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns

Breakout Labs' List of Top Investments

Breakout Labs has a portfolio of 44 companies. Their most notable investments are in Nuclease Probe Technologies and Azitra.Their portfolio spans across United States and Canada. They have invested in Life Sciences, High Tech, HealthTech and 14 other sectors, across stages such as Seed, Grant (prize money)  and 2 more. Here is the list of top investments by Breakout Labs:
Developer of carbon transformation technology for product manufacture. It utilizes water and renewable electricity as inputs and integrates carbon dioxide-reducing catalysts with hardware in order to convert the carbon dioxide into chemicals, materials fuels, and end-products. It aims to reduce the carbon emissions associated with traditional fossil fuel-powered processes and develop carbon-negative materials.

Key facts about Twelve

  • Founded Year: 2015
  • Location: Berkeley (United States)
  • Stage: Series C
  • Total Funding till date: $472M
  • Employee Count: 232 as on Dec 31, 2022
  • Investors: Rising Tide Fund, Mitsui and 53 Others
  • Latest Funding Round: Series C, May 06, 2025, $*****
  • Highlight: Editors' Pick
Developer of micriobiome based therapeutics solution for treating skin atopic dermatitis or eczema. Its lead product is AZT-04 that helps in treating cancer therapy-associated rashes. It has developed other drug candidates in the preclinical stage are AZT-01 which is filaggrin supplementation through bacterial delivery to treat atopic dermatitis or eczema; ATR-12 which contains a proprietary strain of Staphylococcus epidermidis engineered to express therapeutic LEKTI protein to treat Netherton syndrome among others.

Key facts about Azitra

AI-driven biotechnology company that focuses on the discovery and development of novel RNA splicing therapeutics. It offers SpliceCore, is a cloud-based platform that is experimentally validated to predict drug targets and biomarkers through splicing discovery from RNA-seq data, using Artificial Intelligence.

Key facts about Envisagenics

  • Founded Year: 2014
  • Location: Long Island City (United States)
  • Stage: Series B
  • Total Funding till date: $46.8M
  • Employee Count: 27 as on Jul 01, 2024
  • Investors: SV Angel, M12 and 17 Others
  • Latest Funding Round: Series B, Jun 05, 2024, $*****
  • Highlight: Editors' Pick
Internet first brand offering bio-fabricate leather products and accessories. It provides users with a company that provides biofabricated leather which are made from upcycled material such as bio-polymer, and more. The company utilizes nature-inspired protein solutions to enhance performance, sustainability, scalability, and cost-effectiveness while minimizing reliance on petrochemical and animal-based inputs.

Key facts about Modern Meadow

Provider of engineered microbes and biosynthetic pathways for industrial chemicals. The company is re-engineering the microbe and is designing a new biosynthetic pathway to eliminate/reduce the carbon loss in the biological conversion of sugars and other bio-based feedstocks. It claims that the chemicals are produced in the manufacturing of consumer products.

Key facts about Zymochem

Breakout Labs' Investments by Stage

Breakout Labs has made 21 investments in Seed stage with an average round size of $1.12M, 10 investments in Grant (prize money) stage with an average round size of $302K, 1 investment in PE stage and 1 investment in Series A stage with an average round size of $10M.
Here are Breakout Labs' investments by stage:
Stage of entry
No. of Investments
Seed
21
Grant (prize money)
10
PE
1
Series A
1
Breakdown of Breakout Labs' investments by stage of entrySeed (21)Grant (prize money) (10)
Note: We have considered here, only first round of investments

Breakout Labs' Investments by Sector

Breakout Labs has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Sustainability Tech, Chemicals and Materials Tech and Enterprise Applications. Notably, it has invested in 40 Tech companies, 35 Enterprise (B2B) companies, 14 Tech hardware companies and at least 9 companies focusing on Software.
Here are Breakout Labs' investments by sector:
Sector
No. of Investments
Life Sciences
17
High Tech
16
Sustainability Tech
7
Chemicals and Materials Tech
6
Enterprise Applications
5
Others
28
Breakdown of Breakout Labs' investments by sectorsLife Sciences (17)High Tech (16)
Note: We have considered here, only first round of investments

Breakout Labs' Investments by Geography

Breakout Labs has made most investments in United States (33).

Breakout Labs' recent investments

Breakout Labs has not made any investment in 2026 so far.
Here are the most recent investments by Breakout Labs:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Jul 12, 2022
United States
Seed
2847
Mar 05, 2019
United States
Seed
3376
-
Nov 27, 2018
United States
Seed
3413
-
Oct 27, 2018
United States
Seed
7405
-
Sep 25, 2018
United States
Seed
7699

IPOs and Publicly Listed companies in Breakout Labs' Portfolio

2 of Breakout Labs' portfolio companies have become public. Azitra got listed on the American Stock Exchange (NYSEAMERICAN), in Jun 2023 at marketcap of $60.4M and Quince Therapeutics got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $442M.
Here are Breakout Labs' portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Jun 16, 2023
Oct 11, 2016
Seed
6681
May 09, 2019
Jun 11, 2014
Seed
4750

Acquired companies in Breakout Labs' Portfolio

3 companies from Breakout Labs' portfolio have been acquired. The most recent acquisition were FlightWave Aerospace in Sep 2024 by Red Cat.
Here are Breakout Labs' portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Sep 05, 2024
Aug 15, 2017
Seed
1884
Nov 15, 2022
Sep 26, 2017
Seed
8137
Dec 02, 2013
Apr 17, 2013
Grant (prize money)
6952

Team profile of Breakout Labs

Breakout Labs has a team of 2 members including 2 Partners located in United States. Breakout Labs' team sits on the board of 3 companies.

Co-investors of Breakout Labs

Over the past 14 years, 159 investors have co-invested in Breakout Labs's portfolio companies. This includes funds and angels.

  • Invested before Breakout LabsHHS, National Science Foundation and 12 others have invested in rounds before Breakout Labs. There are 6 companies where HHS has invested before Breakout Labs and 5 companies where National Science Foundation has invested before Breakout Labs.
  • Top Co-investors of Breakout Labs13 investors entered a company along with Breakout Labs. These include investors like Horizons Ventures (1 company).
  • Invested after Breakout LabsA total of 132 investors have invested in Breakout Labs's portfolio after their investments. Top Investors include America’s Seed Fund (8 companies), Breakout Ventures (7 companies) and HHS (5 companies).

Recent News related to Breakout Labs

View all news related to Breakout Labs

FAQs about Breakout Labs

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford